For Investors

Press Releases

FDA Issues Clearance for the ReStore™ Exo-Suit, the First Soft Robotic System for Stroke Therapy

06/04/19

New age innovation offers versatile, affordable medical device to U.S. rehab clinics to treat millions of patients with gait impairment MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, June 4, 2019 /PRNewswire/ -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer

ReWalk Robotics Receives CE Mark for ReStore™ Exo-Suit Stroke Rehabilitation Device

05/29/19

Advent of the Soft Exo-Suit Generation expands assistive robotic therapy for stroke survivors MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 29, 2019 /PRNewswire/ -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with

ReWalk Robotics Appoints Chunlin (Allen) Han to its Board of Directors

05/20/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , May 20, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.  (Nasdaq:RWLK) (“ReWalk” or “the Company”) announced today that the Company has appointed Mr. Chunlin (Allen) Han to the board of directors of the Company (the “Board”). Ms.

ReWalk Robotics Reports First Quarter 2019 Financial Results

05/07/19

— 2019 first quarter total revenue of $1.6 million — — Gross margin record of 59% — — On track with ReStore Exo-Suit launch timeline — YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , May 07, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its

ReWalk Robotics to Report First Quarter 2019 Financial Results on May 7, 2019

05/03/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , May 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2019 financial results on Tuesday, May 7, 2019 , before the U.S.

ReWalk Robotics Regains Compliance with Nasdaq Listing Rules 5550(a) and 5550(b)

04/26/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 26, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has regained compliance with Nasdaq Listing Rules 5550(b) (“Rule 5550(b)”) and 5550(a)(2) (“Rule 5550(a)(2)”).

ReWalk Announces Regional Blue Cross Blue Shield Plan Beneficiaries Are Winning Requests to Walk Again

04/25/19

Independent reviewer authorizes coverage of ReWalk system for another paralyzed individual, the 17th by a regional BCBS plan MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 25, 2019 /PRNewswire/ -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that an

ReWalk Robotics to Present at the ThinkEquity Conference on May 2nd

04/23/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , April 23, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski , Chief Executive Officer and Andy Dolan , Vice President of Marketing, will present at the ThinkEquity Conference in

ReWalk Announces First Personal Exoskeleton Provided to Cigna Beneficiary

04/16/19

Reimbursement of the device marks a key milestone in the Company's relationship with major U.S. private insurers. MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , April 16, 2019 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that the first Cigna

ReWalk Robotics Announces Closing of Registered Direct Offering for $4.25 Million Priced At-the-Market

04/05/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 816,914 ordinary shares at a purchase price of $5.2025

ReWalk Robotics Announces Pricing of Registered Direct Offering for $4,250,000

04/03/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 816,914 ordinary

ReWalk Robotics Completes One-for-Twenty-Five Reverse Share Split

03/29/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , March 29, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.  (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) reported today that it has completed the reverse share split of ReWalk ordinary share at a ratio of one-for-twenty-five shares, which will take